Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News EMA approves Dupixent as first biologic for COPD with elevated eosinophils The European Medicines Agency (EMA) has granted approval to Dupixent (dupilumab) as a novel add-on maintenance treatment for… byPallavi MadhirajuJuly 7, 2024